5.28
+0.64
+(13.67%)
At close: April 9 at 4:00:00 PM EDT
5.17
-0.11
(-2.02%)
Pre-Market: 8:21:11 AM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
101,538
149,718
95,050
108,662
Total Liabilities Net Minority Interest
130,431
92,344
47,659
21,103
Total Equity Gross Minority Interest
-28,893
57,374
47,391
87,559
Total Capitalization
11,831
97,460
71,917
87,808
Common Stock Equity
-28,893
57,374
47,391
87,559
Capital Lease Obligations
1,530
1,471
2,264
2,931
Net Tangible Assets
-28,893
57,374
47,391
87,559
Working Capital
63,988
117,302
71,207
87,150
Invested Capital
11,831
97,460
72,192
87,808
Tangible Book Value
-28,893
57,374
47,391
87,559
Total Debt
42,254
41,557
27,065
3,180
Share Issued
40,262
25,281.15
16,711.75
15,440.50
Ordinary Shares Number
40,262
25,281.15
16,711.75
15,440.50
12/31/2021 - 1/27/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRDF Cardiff Oncology, Inc.
2.6100
+2.35%
KPTI Karyopharm Therapeutics Inc.
4.2300
+6.82%
TRVI Trevi Therapeutics, Inc.
5.40
+1.89%
ABEO Abeona Therapeutics Inc.
4.3700
+1.16%
MESO Mesoblast Limited
11.08
+10.47%
ATRA Atara Biotherapeutics, Inc.
5.89
+5.37%
RVMD Revolution Medicines, Inc.
35.12
+12.82%
VNDA Vanda Pharmaceuticals Inc.
4.1300
-0.24%
CAPR Capricor Therapeutics, Inc.
9.40
+8.05%
RIGL Rigel Pharmaceuticals, Inc.
17.26
+5.44%